• 1
    Fierobe L, Lucet JC, Decre D et al. An outbreak of imipenem-resistant Acinetobacter baumannii in critically ill surgical patients. Infect Cont Hosp Epidemiol 2001; 22: 3540.
  • 2
    Poirel L, Menuteau O, Agoli N, Cattoen C, Nordmann P. Outbreak of extended-spectrum β-lactamase VEB-1-producing isolates of Acinetobacter baumannii in a French hospital. J Clin Microbiol 2003; 41: 35423547.
  • 3
    Vincent JL, Bihari DJ, Suter PM, Bruining HA, White J, Nicholas-Chanoine MH. The prevalence of nosocomial infection in intensive care units in Europe. Results of the European prevalence of infection in intensive care (EPIC) study. EPIC International Advisory Committee. JAMA 1995; 274: 639644.
  • 4
    Houang ETS, Chu YW, Leung CM et al. Epidemiology and infection control implications of Acinetobacter spp. in Hong Kong. J Clin Microbiol 2001; 39: 228234.
  • 5
    Rello J. Acinetobacter baumannii infections in the ICU: customization is the key. Chest 1999; 115: 12261229.
  • 6
    Rello J, Diaz E. Acinetobacter baumannii: a threat for ICU. Intens Care Med 2003; 29: 350351.
  • 7
    Wisplinghoff H, Edmond MB, Pfaller MA, Jones RN, Wenzel RP, Seifert H. Nosocomial blood stream infections caused by Acinetobacter species in United States hospitals: clinical features, molecular epidemiology, and antimicrobial susceptibility. Clin Infect Dis 2000; 31: 690697.
  • 8
    Livermore DM. The threat from the pink corner. Ann Med Int 2003; 35: 226234.
  • 9
    Theaker C, Azadian B, Soni N. The impact of Acinetobacter baumannii in the intensive care unit. Anaesthesia 2003; 58: 271274.
  • 10
    Fagon JY, Chastre J, Domart Y, Trouillet JL, Gibert C. Mortality due to ventilator-associated pneumonia or colonization with Pseudomonas or Acinetobacter species. Assessment by quantitative culture of samples obtained by a protected specimen brush. Clin Infect Dis 1996; 23: 538542.
  • 11
    Wang SH, Sheng WH, Chang YY et al. Healthcare-associated outbreak due to pan-drug resistant Acinetobacter baumannii in a surgical intensive care unit. J Hosp Infect 2003; 53: 97102.
  • 12
    Blot S, Vandewoude K, Colardyn F. Nosocomial bacteremia involving Acinetobacter baumannii in critically ill patients; a matched cohort study. Intens Care Med 2003; 29: 471475.
  • 13
    Smolyakov R, Borer A, Riesenberg K et al. Nosocomial multi-drug resistant Acinetobacter baumannii bloodstream infection: risk factor and outcome with ampicillin–sulbactam treatment. J Hosp Infect 2003; 54: 3238.
  • 14
    Garnacho J, Sole-Violan J, Sa-Borges M, Diaz E, Rello J. Clinical impact of pneumonia caused by Acinetobacter baumannii in intubated patient: a matched cohort study. Crit Care Med 2003; 10: 24782482.
  • 15
    Chen CH, Lin LC, Chang YJ, Huang CC, Liu CE, Young TG. Analysis of prognostic factors in 95 patients with Acinetobacter baumannii bacteremia. Infection 2003; 31: 331335.
  • 16
    Kaul R, Burt JA, Cork L et al. Investigation of a multiyear multiple critical care unit outbreak due to relatively drug-sensitive Acinetobacter baumannii; risk factors and attributable mortality. J Infect Dis 1996; 174: 12791287.
  • 17
    Towner KJ. Clinical importance and antibiotic resistance of Acinetobacter spp. J Med Microbiol 1997; 46: 721746.
  • 18
    Vaque J, Rossello J, Arribas JL. Prevalence of nosocomial infections in Spain: EPINE study 1990–1997. EPINE Working Group. J Hosp Infect 1999; 43: S105S111.
  • 19
    Poutanen SM, Louie M, Simor AE. Risk factors, clinical features and outcome of Acinetobacter bacteremia in adults. Eur J Clin Microbiol Infect Dis 1997; 16: 737740.
  • 20
    Valero C, Garcia Palomo JD, Mattoras P, Fernandez-Mazarrasa C, Gonzales-Fernandez C, Farinas MC. Acinetobacter bacteraemia in a teaching hospital, 1989–1998. Eur J Int Med 2001; 12: 425429.
  • 21
    Obana Y. Pathogenic significance of Acinetobacter calcoaceticus: analysis of experimental infection in mice. Microbiol Immunol 1986; 30: 645657.
  • 22
    McDonald LC, Banerjee SN, Jarvis WR. Seasonal variation of Acinetobacter infections: 1987–1996. Nosocomial Infections Surveillance System. Clin Infect Dis 1999; 29: 11331137.
  • 23
    Gales AC, Sader HS, Jones RN. Respiratory tract pathogens isolated from patients hospitalized with suspected pneumonia in Latin America: frequency of occurrence and antimicrobial susceptibility profile: results from the SENTRY Antimicrobial Surveillance Program (1997–2000). Diagn Microbiol Infect Dis 2002; 44: 301311.
  • 24
    Saulnier FF, Hubert H, Onimus TM et al. Assessing excess nurse work load generated by multiresistant nosocomial bacteria in intensive care. Infect Cont Hosp Epidemiol 2001; 22: 273278.
  • 25
    Cardenosa Cendrero JA, Sole-Violan J, Bordez Benitez A et al. Role of different routes of tracheal colonization in the development of pneumonia in patients receiving mechanical ventilation. Chest 1999; 116: 462470.
  • 26
    Ehrlich RL, Steele MS, Sabatini NJ, Benner C. Acinetobacter infection in hospitals. Clin Alert 2003; 2: 1.
  • 27
    Wagenvort JHT, De Brauwer EIGB, Toenbreker HMJ, Van Der Linden CJ. Epidemic Acinetobacter baumannii strain with MRSA-like behaviour carried by healthcare staff. Eur J Clin Microbiol Infect Dis 2002; 21: 326327.
  • 28
    Anstey NM, Currie BJ, Hassell M, Palmer D, Dwyer B, Seifert H. Community-acquired bacteremic Acinetobacter pneumonia in tropical Australia is caused by diverse strains of Acinetobacter baumannii, with carriage in the throat in at-risk groups. J Clin Microbiol 2002; 40: 685686.
  • 29
    Wang JT, McDonald LC, Chang SC, Ho M. Community-acquired Acinetobacter baumannii bacteremia in adult patients in Taiwan. J Clin Microbiol 2002; 40: 15261529.
  • 30
    Salas Coronas J, Cabezas Fernandez T, Alvarez-Ossorio Garcia de Soria R, Diez Garcia F. Community-acquired Acinetobacter baumannii pneumonia. Rev Clin Esp 2003; 203: 284286.
  • 31
    Megarbane B, Bruneel F, Bedos JP, Wolff M, Regnier B. Acinetobacter baumannii community-acquired pneumonia in a patient with HIV infection. Presse Med 2000; 29: 788789.
  • 32
    La Scola B, Fournier PE, Brouqui P, Raoult D. Detection and culture of Bartonella quintana, Serratia marscesens, and Acinetobacter spp. from decontaminated human body lice. J Clin Microbiol 2001; 39: 17071709.
  • 33
    Oncul O, Keskin O, Acar HV et al. Hospital-acquired infections following the 1999 Marmara earthquake. J Hosp Infect 2002; 51: 4751.
  • 34
    Centers for Disease Control and Prevention. Acinetobacter baumannii infections among patients at military medical facilities treating injured US service members, 2002–2004. MMWR 2004; 53: 10631066.
  • 35
    Rathinavelu S, Zavros Y, Merchant JL. Acinetobacter lwoffii infection and gastritis. Microb Infect 2003; 5: 651657.
  • 36
    Wilson C, Hughes L, Rashid T et al. Antibodies to prion and Acinetobacter peptide sequences in bovine spongiform encephalopathy. Vet Immunol Immunopathol 2004; 98: 17.
  • 37
    Bergogne-Berezin E, Joly-Guillou ML, Towner KJ, eds. Acinetobacter: microbiology, epidemiology, infections, management. Boca Raton, FL: CRC Press, 1996.
  • 38
    Goel VK, Kapil A. Monoclonal antibodies against the iron regulated outer membrane proteins of Acinetobacter baumannii are bactericidal. BMC Microbiol 2001; 1: 1624.
  • 39
    Gonzalez RH, Nusblat A, Nudel BC. Detection and characterization of quorum sensing signal molecules in Acinetobacter strains. Microbiol Res 2001; 155: 271277.